Gara Oneil, MA, LPC, NCC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 686a Deer Creek Rd, Valencia, PA 16059 Phone: 724-996-9655 |
Emily Lauren Stokoski, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 4304 Senate Ct, Valencia, PA 16059 Phone: 313-505-4071 |
Nichole Barrett, MA Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 2016 Condor Dr, Valencia, PA 16059 Phone: 724-201-9593 |
News Archive
According to the Centers for Disease Control and Prevention, about 28% of adolescents are overweight. This means that about 1 in every 5 parents is thinking about how to discuss this with their child. Creating a healthful home environment, modeling healthful behaviors, and providing encouragement and support to adolescents for positive behavior changes may be more effective than communicating with adolescents about weight-related topics, according to a new study released in the November/December 2012 issue of the Journal of Nutrition Education and Behavior.
The Miami Project to Cure Paralysis, a Center of Excellence at the University of Miami Miller School of Medicine, has received permission from the Food and Drug Administration to begin a revolutionary Phase 1 clinical trial to evaluate the safety of transplanting human Schwann cells to treat patients with recent spinal cord injuries.
An international consortium of scientists of Helmholtz Zentrum München and the University of Toronto has identified previously unknown potential disease genes in humans and mice. Genes on the X chromosome, which regulate embryonic development, are the focus of the current publication in the renowned journal Genome Research. Men have only one X chromosome, and therefore mutations on this chromosome disproportionately affect males, frequently leading to serious diseases such as hemophilia, muscular dystrophy and mental retardation.
California is also preparing for a boom of children who will soon qualify for dental care in the Medicaid program. In the meantime, transitions in the Kansas' Medicaid program encounter problems.
Pharmasset, Inc., announced today positive data from interim analyses of two of its clinical programs: the HCV genotype 2 or 3 (GT2/3) arm of the PSI-7977 Phase 2b trial and the 14 day PSI-938 monotherapy cohort of the dual nucleotide study.
› Verified 9 days ago